AI Rising Stars: Small-Cap Stocks Poised for Big Growth
Artificial intelligence (AI) continues to revolutionize industries, with companies like Palantir Technologies dominating the AI-driven data analytics space. Trading at $154 in 2025 and boasting a remarkable 105% year-to-date gain, Palantir has cemented itself as a leader. However, two sub-$10 AI stocks, BigBear.ai and Lantern Pharma, have emerged as under-the-radar contenders with the potential to outperform Palantir by 2026.
1. BigBear.ai – Transforming Government AI
BigBear.ai (NYSE: BBAI) is making waves with its recent acquisition of Ask Sage, a generative AI platform tailored for secure and regulated industries. Ask Sage already serves over 100,000 users across 16,000 government teams, contributing an estimated $25 million in annual recurring revenue for 2025. This strategic move allows BigBear to expand from decision-intelligence tools into a full-stack generative AI provider.
With over $450 million in cash reserves, BigBear.ai is well-positioned to accelerate its growth initiatives, scale its operations, and explore further acquisitions. As of now, BBAI stock is trading at $5.40, reflecting a robust 20% gain in the market.
2. Lantern Pharma – Innovating Cancer Drug Development
Lantern Pharma (NASDAQ: LTRN) is revolutionizing oncology through its proprietary RADR AI platform. Built on over 200 billion data points, the RADR platform incorporates cutting-edge algorithms to predict therapeutic results, such as blood-brain-barrier permeability through the predictBBB.ai tool. Key advancements like the LP-184 Phase 1a trial have shown promising results, boasting a 48% clinical benefit rate among highly pre-treated patients.
The company also plans to commercialize its RADR platform for broader use in R&D, potentially creating new revenue streams. Lantern Pharma stock is currently valued at $3.02, making it an affordable entry point for investors interested in groundbreaking biotech solutions.
Should You Invest in These AI Contenders?
While Palantir remains a titan in AI-driven intelligence, emerging players like BigBear.ai and Lantern Pharma are carving distinct niches. For instance, BigBear.ai’s focus on secure government AI and Lantern Pharma’s robust innovations in oncology make them compelling growth opportunities. However, risks such as cash burn, integration challenges, and regulatory hurdles cannot be ignored.
A Stock Trading Tool to Consider
Before diving into investments, using trading platforms with advanced tools is invaluable. Platforms like eToro allow users to trade stocks, cryptocurrencies, and more seamlessly. You can start from as little as $10 and even copy successful traders in real-time. Learn more about trading on eToro here.
Ultimately, an informed approach based on data and market trends can help investors capitalize on these emerging opportunities.
